Interest Group on Supranational Biolaw
The Interest Group on Supranational Biolaw from the European Association of Health Law (EAHL) aims to promote European health law, especially in its European-level dimension. ‘Supranational biolaw’ is understood as comprising the law of the European Union, the Council of Europe and the European Patent Organisation, regarding the law and the various legal issues arising from technological advances related to medicine and biotechnology.
While Supranational Biolaw in all its dimensions is often not understood as valuable in and of itself, it underpins or is inflected within national law, and is now so developed that it can no longer be ignored.
Through research, training and networking activities, the types of activities that correspond to the activities of EAHL, the EAHL Interest Group on Supranational Biolaw will help to effectively mobilise its Members to address demands from several groups within society, including legislators and regulators, scientists (researchers and clinicians), and patients regarding Supranational Biolaw. The Interest Group will also help to strengthen the position of academics within national level systems and political contexts that threaten their autonomy and role as facilitators of freedom of discussion.
Current members include: Dobrochna Bach-Golecka (Poland); Estelle Brosset (France); Joaquin Cayon (Spain); Brenda Daly (Ireland); Nathalie De Grove-Valdeyron (France); Anne-Marie Duguet (France); Mirko Dukovic (Hungary); Inesa Fausch (Switzerland); Mark Flear (United Kingdom); Markus Frischhut (Austria); Eloïse Gennet (France); Matthieu Guerriaud (France); Mary Guy (United Kingdom); Edouard Habib (France); Tamara Hervey (United Kingdom); Clotilde Jourdain-Fortier (France); Kaisa-Maria Kimmel (Finland); Michal Koscik (Czech Republic); Phoebe Li (United Kingdom); Pin Lean Lau (United Kingdom); Aurélie Mahalatchimy (France); Jean McHale (United Kingdom); Isabelle Moine-Dupuis (France); Andrea Mulligan (Ireland); Stefania Negri (Italy); Vera Lucia Raposo (Portugal); Emmanuelle Rial-Sebbag (France); Sabrina Roettger-Wirtz (The Netherlands); Judit Sandor (Hungary); Mike Schwebag (Luxembourg); Claudia Seitz (Switzerland); Santa Slokenberga (Sweden); Tomislav Sokol (Croatia).
Chairs: Aurélie Mahalatchimy (UMR 7318 DICE CERIC, CNRS, Aix Marseille University, Toulon University, Pau & Pays de l’Adour University, France) and Mark Flear (Queen’s University Belfast, UK)
General manager: Pin Lean Lau (Brunel University, UK)
Communication managers: Mirko Dukovic (Central European University, Hungary) and Edouard Habib (Aix-Marseille University, France)
Gene and Cell Therapy Institute
G&CTI est un groupe de réflexion libre, indépendant, à but non lucratif et au service de l’intérêt général. Il a pour objectif de rassembler l’ensemble des acteurs de la Santé en France afin de devenir un acteur majeur du débat démocratique, en favorisant le dialogue et l’émergence d’une vision à long terme au sujet des thérapies géniques et cellulaires.
Régie par la loi 1901 des associations, G&CTI propose une structure équilibrée, neutre, pluraliste et efficace, ce think tank s’articule autour de 5 collèges représentant l’ensemble des acteurs de la Santé.
i-Gen
i-GEN focus on researchers and experts from different disciplines and countries working on legal, economic, regulatory, cultural, ethical, and political aspects of genome editing technologies.
The network is intended to help share ideas, resources and information about developments and practices in different countries and fields, make connections and initiate discussions and conversations that can provide a foundation for future work.
In support of these goals, i-GEN is developing a database of members, as a publicly available resource in order to help governments, civil servants, researchers, NGOs, policy-makers, journalists, media and interested private citizens to find academic experts in a particular location (e.g. Portugal, or Singapore), with interests in a particular area of application of genome editing (e.g. medical uses or plant breeding) or working in a particular disciplinary background (e.g. law or science communication) and to engage them in activities of interest.
To know more, visit their website.
The Pluridisciplinary Thematic Network in Human and Social Sciences on Genetics and Genomic Medicine
The Pluridisciplinary Thematic Network in Human and Social Sciences on Genetics and Genomic Medicine (RTP SHS GenMed) aims to structure research in human and social sciences, on genetics and genomic Medicine, and more specifically on their ethical, political and epistemological stakes.
International Association of Law, Ethics & Science (IALES)
The International Association of Law, Ethics & Science, founded in 1989, constitutes an international network for reflection, research and debate in the field of the relationships between science, ethics and society. It mobilizes, for the benefit of the international community and citizens, a knowledge and a multidisciplinary and pluricultural experience making it possible to restore the complexity of the questions raised by the rise of technosciences and the social transformations that they imply.
Website under construction
Association for Studies in Innovation, Science and Technology- UK (AsSIST- UK)
AsSIST-UK supports transdisciplinary collaboration across the social sciences, humanities and sciences in the field of science, innovation and technology. It supports the training of new scholars in the field, engagement with civil society, government and industry within the UK and globally.
Ethical, Legal and Social Implications 2.0 (ELSI 2.0)
ELSI2.0 aims to encourage international collaboration and discussion around the Ethical, Legal and Social Implications of research in the Life Sciences.
GDR NOST
Le groupe de recherche « Normes, Sciences et Techniques » a pour mission de mettre en réseau les activités des équipes membres afin d’engendrer un renouvellement des problématiques liées aux normativités à l’œuvre dans le domaine des sciences et techniques.